GenMont Biotech Incorporation announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 86.240 million compared to TWD 97.413 million a year ago. Operating income was TWD 17.690 million compared to TWD 23.014 million a year ago. Net income was TWD 4.176 million compared to TWD 93.073 million a year ago. Basic earnings per share from continuing operations was TWD 0.05 compared to TWD 0.12 a year ago. Basic earnings per share was TWD 0.05 compared to TWD 1.05 a year ago. Diluted earnings per share was TWD 0.05 compared to TWD 1.04 a year ago. For the half year, sales was TWD 177.328 million compared to TWD 193.528 million a year ago. Operating income was TWD 43.253 million compared to TWD 50.399 million a year ago. Net income was TWD 45.337 million compared to TWD 97.127 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.42 a year ago. Basic earnings per share was TWD 0.51 compared to TWD 1.09 a year ago.